NLS Iceland

From August 18-24, 2026, patients, physicians, caregivers, and supporters from around the world will embark on a six-day cycling expedition across Iceland with the purpose of accelerating research into multiple myeloma.

The FDA has issued a complete response letter (CRL) for Alvotech’s Biologics License Application (BLA) for AVT05, in a prefilled syringe and autoinjector presentations, a biosimilar candidate to Simponi (golimumab).

The two companies have announced the availability of SELARSDI injection in the US for the treatment of psoriatic arthritis, plaque psoriasis, Crohn’s disease, ulcerative colitis, pediatric plaque psoriasis and pediatric psoriatic arthritis.

Scientists at deCODE genetics have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s Disease.

A new study from deCODE genetics and collaborators is the first to uncover a strong recessive component in Alzheimer’s disease. deCODE genetics/Amgen, and collaborators from Iceland, USA, UK, Denmark, Norway, and Sweden recently published the study: “Homozygosity for a missense variant in R47H in TREM2 and the Risk of Alzheimer’s Disease”, in New England Journal […]

Icelandic deCODE genetics and its collaborators employed artificial intelligence (AI) to develop a protein score to predict major atherosclerotic cardiovascular disease events. In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics and collaborators from USA, Denmark, and Iceland, reported in The Journal […]